Fused Pyrimidine-Based Drug Discovery
Raj Kumar (Redaktør)
Fused Pyrimidine-Based Drug Discovery covers all categories of fused-pyrimidines along with pharmacological and in silico
studies. It covers the chemistry and biological activities, as well as the design of novel fused-pyrimidine scaffolds. Les mer
- Vår pris
- 2954,-
(Paperback)
Fri frakt!
Leveringstid:
Sendes innen 21 dager
Paperback
Legg i
Paperback
Legg i
Vår pris:
2954,-
(Paperback)
Fri frakt!
Leveringstid:
Sendes innen 21 dager
Fused Pyrimidine-Based Drug Discovery covers all categories of fused-pyrimidines along with pharmacological and in silico
studies. It covers the chemistry and biological activities, as well as the design of novel fused-pyrimidine scaffolds. N-Heterocyclic
scaffolds are found in most known drug candidates, and are of interest to medicinal and organic chemists to design, synthesize
and evaluate their biological properties. A variety of fused-pyrimidine molecules have been synthesized and extracted from
natural resources, and are found to exhibit various biological activities such as antifolates, anticancer agents, analgesics,
antimetabolites, CNS active agents and many more. Some of these scaffolds like purines are also known to have involvement
in biological processes and are part of the framework of genetic material. This book focuses on the classification, structural
chemistry, and chemical and physical properties along with various approaches for their synthesis. This book is ideal for
researchers in organic chemistry both in academic and industrial settings, postgraduates in chemistry and medicinal chemistry.
- FAKTA
-
Utgitt:
2022
Forlag: Elsevier - Health Sciences Division
Innbinding: Paperback
Språk: Engelsk
ISBN: 9780443186165
Format: 23 x 15 cm
- KATEGORIER:
- VURDERING
-
Gi vurdering
Les vurderinger
1. Introduction 2. FDA Approved Fused Pyrimidine-Based Drugs 3. Naturally occurring fused pyrimidine derivatives and Medicinal
Attributes 4. Five-Membered Ring Fused Pyrimidine-Based Derivatives and Biological Properties 5. FDA approved Five-Membered
Ring Fused Pyrimidine-Based Derivatives and Biological Properties 6. Benzene Fused Pyrimidine-Based Derivatives and their
Biological Properties 7. Six-Membered Ring (with N, O or S) Fused Pyrimidine-Based Derivatives and Biological Properties 8.
FDA approved Six-Membered Ring Fused Pyrimidine-Based Derivatives 9. Seven-Membered Ring Fused Pyrimidine-Based Derivatives
and Biological Properties 10. Eight-Membered Fused Pyrimidine Derivatives and Biological Properties 11. Molecular Modeling
Studies of Fused Pyrimidine Derivatives at various receptors
Dr. Raj Kumar, FRSC, is currently working as Dean of School of Health Sciences, and a Professor at the Department of Pharmaceutical
Sciences and Natural Products, Central University of Punjab, Bathinda, India. He obtained his Ph.D. in Medicinal Chemistry
(2007) from NIPER, Mohali, India and completed his postdoctoral fellowship (2007-2008) at the University of Maryland Baltimore
County (UMBC), Maryland where he co-invented a fused heterocycle RK-33 (Raj Kumar-33) molecule for the treatment of Lung Cancer.
Dr. Kumar has published more than 90 peer-reviewed research papers (h index = 33; Scopus) in leading Medicinal/Organic/Pharmaceutical
Chemistry Journals with a cumulative impact factor > 300. Dr. Kumar has been featured in the list of top 2% international
scientists “Updated Science-wide Database of Stanford Citation Indicators released by Stanford University, USA and published
by Elsevier BV on 19th October 2021. His research interests focus on the design and synthesis of novel fused heterocycles
of biological importance.